Phase 1 Malignant Solid Tumors Clinical Trials
19 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–19 of 19 trials
Recruiting
Phase 1
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Colorectal, CancerMesothelin-Expressing TumorsEpithelial Ovarian Cancer+8 more
Context Therapeutics Inc.70 enrolled9 locationsNCT06756035
Recruiting
Phase 1Phase 2
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc.428 enrolled7 locationsNCT07287995
Recruiting
Phase 1
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors
Advanced/Metastatic Malignant Solid Tumors
Shanghai Henlius Biotech367 enrolled10 locationsNCT06115642
Recruiting
Phase 1Phase 2
A Study of TAK-505 in Adults With Solid Tumors
Malignant Solid Tumors
Takeda151 enrolled15 locationsNCT07436728
Recruiting
Phase 1
Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors
Advanced malignant solid tumorsMetastatic Malignant Solid Tumors
Genmab45 enrolled5 locationsNCT06573294
Recruiting
Phase 1
Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.
Refractory Malignant Solid TumorsmRNA VaccineInterleukin
West China Hospital6 enrolled2 locationsNCT07040943
Recruiting
Phase 1Phase 2
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
Advanced malignant solid tumors
FindCure Biosciences (ZhongShan) Co., Ltd.33 enrolled1 locationNCT06499350
Recruiting
Phase 1
A Study of CSCJC3456 in Patients With Advanced Malignant Tumors
Advanced malignant solid tumors
Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.102 enrolled2 locationsNCT06717750
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors
Malignant Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.300 enrolled1 locationNCT06737731
Recruiting
Phase 1
A Clinical Trial Evaluating IL-22BP/LNP Compound in Refractory Malignant Solid Tumors for Safety, Tolerability and Activity
Refractory Malignant Solid TumorsmRNA VaccineInterleukin
Xingchen Peng6 enrolled1 locationNCT07100210
Recruiting
Phase 1
JSKN022 in Subjects With Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd225 enrolled1 locationNCT07292402
Recruiting
Phase 1
MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors
B7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors
Zhejiang University12 enrolled1 locationNCT06912152
Recruiting
Phase 1
Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors
Advanced malignant solid tumors
Shanghai Junshi Bioscience Co., Ltd.93 enrolled1 locationNCT06571422
Recruiting
Phase 1Phase 2
A Study of GQ1010 in Subjects With Advanced Solid Tumors
Advanced malignant solid tumors
GeneQuantum Healthcare (Suzhou) Co., Ltd.260 enrolled5 locationsNCT06464055
Recruiting
Phase 1
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Peking University Cancer Hospital & Institute13 enrolled1 locationNCT06728189
Recruiting
Phase 1
A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Mabwell (Shanghai) Bioscience Co., Ltd.40 enrolled2 locationsNCT05773937
Recruiting
Phase 1
Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors
CDH17-positive Advanced Malignant Solid Tumors
Shanghai Pudong Hospital17 enrolled1 locationNCT06501183
Recruiting
Phase 1
A Study of HMPL-415S1 in Patients With Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Hutchmed81 enrolled1 locationNCT05886374
Terminated
Phase 1
A first-in-human study of VG161 in participants with advanced malignant tumours that have not responded to conventional therapies.
Advanced malignant solid tumors
Virogin Biotech Australia Pty. Ltd.36 enrolled3 locationsACTRN12620000244909